Informação sobre produto
MKC 9989 is a small molecule that is designed to target cancer cells. It has been shown to cause cell dysfunction by binding to lysine residues on the surface of cancer cells and removing proton from the cell, which impairs its ability to function. MKC 9989 also binds to hydrogen bonds on the surface of cancer cells and prevents them from forming imines, which are important for cellular metabolism. This drug has been shown to be effective in treating cancers in animal models and may be used as an alternative treatment option for patients who have not responded well to other therapies such as chemotherapy or radiation therapy.
Propriedades químicas
Consulta técnica sobre: 3D-NDC93420 MKC9989
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.
